Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Cholestyramine Colestipol Colesevelam |
|
|
Term
|
Definition
Atorvastatin Pravastatin Lovastatin |
|
|
Term
What are Gemfibrozil and Fenofibrate ligands for? |
|
Definition
|
|
Term
Gemfibrozil Fenofibrate increases ______ catabolism and reduces _____ |
|
Definition
FA VLDL so you increase turnover of fats |
|
|
Term
Gemfibrozil Fenofibrate used to treat____ |
|
Definition
|
|
Term
what mainly do Gemfibrozil Fenofibrate do? |
|
Definition
lower triglycerides and raise HDL |
|
|
Term
Gemfibrozil Fenofibrate pharmackinetics? |
|
Definition
absorbed from GI and goes enterohepatic circulation.
eliminated through kidneys |
|
|
Term
|
Definition
rare cases of rash, GI symptoms, myopathy, arrhythmias, hypokalemia & high aminotransferase or alkaline phosphatase levels, risk of cholesterol gallstones. |
|
|
Term
Drug interactions of Gemfibrozil Fenofibrate |
|
Definition
increase anticoagulent effect |
|
|
Term
contraindications Gemfibrozil Fenofibrate |
|
Definition
dont use in pts with liver or renal dysfunction |
|
|
Term
whats the major drug in nicotinic acid? |
|
Definition
|
|
Term
what does the nicotinic acid do? |
|
Definition
treats combined dyslipidemias(excess lipid in blood)
lower LDL and VLDL levels
inhibit lipolysis in adipose tissue receptor...reduces camp and inhibits hormone sensitive lipase -reduce FA, VLDL synthesis and LDL levels -lowers triglycieride and LP |
|
|
Term
what are some side effects of niacine? |
|
Definition
flushing, hyperuricemia, glucose intolerance, and hepatic dysfunction |
|
|
Term
what are some contraindicatins of niacin? |
|
Definition
|
|
Term
what are bile acid binding resins? |
|
Definition
colestipol and cholestryamine |
|
|
Term
how do the c bile acid binding resins work? |
|
Definition
binds bile acids in the intestine and its pooped out prevent bile reasportion b/c no bile acids in poop -> u have liver sensing u need more bile acids then you have increased oxidation of cholesterol to bile acids
Results: incerase in LDL RECEPTORS..and you lower LDL serum levels |
|
|
Term
so what do colestipol and cholestyramine do? |
|
Definition
lower ldl increase HDL and TG |
|
|
Term
pharmacokinetics of bile acid binding resins? |
|
Definition
|
|
Term
what are the side effects of bile acid binding resins? |
|
Definition
consitpation-may cause increase in VLDL so add a naicain if they dont have LDL receptor..then doesnt work. bc drug increases LDL receptor |
|
|
Term
what are drug interacitons |
|
Definition
interfere with normal fat digestion and abosrption and stop absorption of VIT A D E K |
|
|
Term
WHAT ARE D HMG co-a reducatase inhibitors? |
|
Definition
|
|
Term
what do the d hmg coa reductase inhibitors do? |
|
Definition
they are competitive inhibitors of hmg-coa reducatse they DEC LDL
induction leads to making lots of LDL receptors
lower serum LDL levels
increasing LDL receptors is the most imprortant part of the mech |
|
|
Term
statins-what effect do they have on bones? |
|
Definition
inhibit osteoclastic activity |
|
|
Term
what are side effects of statins? |
|
Definition
Elevations of serum aminotransferase, doesn't result in hepatotoxicity In 2% of patients who have liver dz maybe have > 3x elevations in aminotransferase levels and that may indicate HEPATOTOXICITY
myositis(muscle pain) rhabdomyolysis-> making myoglobinemia -> may lead to acute renal failure. |
|
|
Term
Drug interacctions of statins |
|
Definition
drugs that compete for CYP3A4 OR CYP2C9 Drugs that induce CYP will lower plasma statin levels |
|
|
Term
Contraindications for statins |
|
Definition
Preggers due to potential teratogenicity |
|
|
Term
|
Definition
lowers uptake of gi cholesterol(both dietary and biliary)
makes lots of high affinity ldl -> removal of LDL from blood |
|
|
Term
waht effect does serum ldl and triglycerides does ezemtibme have? |
|
Definition
|
|
Term
what are an indication with ezetimibe? |
|
Definition
lots of cholesterol(hypercholesterolemia) |
|
|
Term
how do u get toxicity with ezetimibe? |
|
Definition
with HMG COA reducatse inhibitors |
|
|